These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38302369)

  • 21. Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson's disease.
    Vastegani SM; Khoshnam SE; Mansouri E; Hajipour S; Ghafouri S; Bakhtiari N; Sarkaki A; Farbood Y
    Behav Brain Res; 2023 Feb; 437():114100. PubMed ID: 36075399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy.
    Van Laar AD; Webb KR; Keeney MT; Van Laar VS; Zharikov A; Burton EA; Hastings TG; Glajch KE; Hirst WD; Greenamyre JT; Rocha EM
    NPJ Parkinsons Dis; 2023 Aug; 9(1):121. PubMed ID: 37567894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson's Disease.
    Dhanalakshmi C; Janakiraman U; Manivasagam T; Justin Thenmozhi A; Essa MM; Kalandar A; Khan MA; Guillemin GJ
    Neurochem Res; 2016 Aug; 41(8):1899-910. PubMed ID: 27038927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenothiazine normalizes the NADH/NAD
    Tapias V; McCoy JL; Greenamyre JT
    Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats.
    Mansour HM; Fawzy HM; El-Khatib AS; Khattab MM
    Neurochem Int; 2021 Nov; 150():105178. PubMed ID: 34481907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
    Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
    Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.
    Naughton C; Moriarty N; Feehan J; O'Toole D; Dowd E
    Behav Brain Res; 2016 Jan; 296():451-458. PubMed ID: 26393432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.
    Concannon RM; Okine BN; Finn DP; Dowd E
    Exp Neurol; 2016 Sep; 283(Pt A):204-12. PubMed ID: 27317300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
    Rahimmi A; Khosrobakhsh F; Izadpanah E; Moloudi MR; Hassanzadeh K
    Brain Res Bull; 2015 Apr; 113():34-40. PubMed ID: 25732239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roflumilast escalates α-synuclein aggregate degradation in rotenone-induced Parkinson's disease in rats: Modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress.
    Desouky MA; George MY; Michel HE; Elsherbiny DA
    Chem Biol Interact; 2023 Jul; 379():110491. PubMed ID: 37105514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological validation of TDO as a target for Parkinson's disease.
    Perez-Pardo P; Grobben Y; Willemsen-Seegers N; Hartog M; Tutone M; Muller M; Adolfs Y; Pasterkamp RJ; Vu-Pham D; van Doornmalen AM; van Cauter F; de Wit J; Gerard Sterrenburg J; Uitdehaag JCM; de Man J; Buijsman RC; Zaman GJR; Kraneveld AD
    FEBS J; 2021 Jul; 288(14):4311-4331. PubMed ID: 33471408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
    Michel HE; Tadros MG; Esmat A; Khalifa AE; Abdel-Tawab AM
    Mol Neurobiol; 2017 Sep; 54(7):4866-4878. PubMed ID: 27514753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum to "Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia" [Eur. J. Radiol. 144 (2021) 109985].
    Azamat S; Arslan DB; Erdogdu E; Kicik A; Cengiz S; Eryürek K; Tufekcioğlu Z; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
    Eur J Radiol; 2022 Dec; 157():110570. PubMed ID: 36327858
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study.
    Kamal RE; Menze E; Albohy A; Ahmed HI; Azab SS
    Eur J Pharmacol; 2022 Oct; 932():175204. PubMed ID: 35964655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.
    Azmy MS; Menze ET; El-Naga RN; Tadros MG
    Mol Neurobiol; 2018 Aug; 55(8):6572-6588. PubMed ID: 29327204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease.
    Miyazaki I; Isooka N; Imafuku F; Sun J; Kikuoka R; Furukawa C; Asanuma M
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms.
    Mansour HM; Mohamed AF; Khattab MM; El-Khatib AS
    Food Chem Toxicol; 2023 Nov; 181():114069. PubMed ID: 37820786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain polar phenol content, behavioural and neurochemical effects of Corinthian currant in a rotenone rat model of Parkinson's disease.
    Fanarioti E; Tsarouchi M; Vasilakopoulou PB; Chiou A; Karvelas M; Karathanos VT; Dermon CR
    Nutr Neurosci; 2023 Jul; 26(7):652-666. PubMed ID: 35656969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.